Home Nucleus Pharmaceuticals U.S. Cancer Photodynamic Therapy Market to 2032

U.S. Cancer Photodynamic Therapy Market to 2032

Overview

The U.S. Cancer Photodynamic Therapy Market is expected to reach a 2.07 USD Billion by 2032 and is projected to grow at a CAGR of 6.38% from 2025 to 2032.

Revenue, 2024 (USD Billion)
1.27
Forecast, 2032 (USD Billion)
2.07
CAGR, 2024 - 2032
6.38%
Report Coverage
U.S.

U.S. Cancer Photodynamic Therapy Market 2018-2032 USD Billion

U.S. Cancer Photodynamic Therapy Market, Key Findings (2025-2032)

Market Growth and Projections:

  • Market Size (2024): 1.27 USD Billion
  • Projected Market Size (2032): 2.07 USD Billion
  • CAGR (2025-2032): 6.38%

Key Findings of U.S. Cancer Photodynamic Therapy Market

  • The U.S. Cancer Photodynamic Therapy Market was valued at 1.27 USD Billion in 2024.
  • The U.S. Cancer Photodynamic Therapy Market is likely to grow at a CAGR of 6.38% during the forecast period of 2024 to 2032.
  • In 2024, the Largest segment Early-Stage Cancer in Disease Stage Segment accounted for the largest share of the market with a revenue of 1.03 USD Billion
  • The fastest growing segment Hospitals in End User Segment grew Fastest with a CAGR of 7.18% during the forecast period from 2024 to 2032.

U.S. Cancer Photodynamic Therapy Market Scope

U.S. Cancer Photodynamic Therapy Market Segmentation & Scope
Distribution Channel
  • Others
  • Online
  • Third Party Distributors
  • Direct Tender
End User
  • Others
  • Academic & Research Institutes
  • Ambulatory Surgical Centers (ASCS)
  • Dermatology & Skin-cancer clinics
  • Hospitals
Cancer Indication
  • Prostate
  • Cervical
  • Bladder
  • Lung
  • Esophagal
  • Head & Neck
  • Skin & Cutaneous Oncology
Patient Demographics
  • Pediatric
  • Adults
  • Geriatric
Disease Stage
  • Late-Stage Cancer
  • Early-Stage Cancer
Procedure Technique
  • Others
  • Interstitial (Internal) Delivery
  • Intracavitary (Endoscopic) Delivery
  • External Beam
Therapy Modality
  • Others
  • Palliation therapy
  • Adjunctive therapy
  • Standalone therapy
Product Type
  • Photodynamic Therapy Devices
  • Photosensitizer Drugs

U.S. Cancer Photodynamic Therapy Market Data Coverage Insights

Study Period 2024-2032
Base Year 2024
Unit Revenue in USD Billion
Market Value in 2024 1.27 USD Billion
Market Value in 2032 2.07 USD Billion
CAGR (2025-2032) 6.38%
Historic Data 2016-2023
Market Segments Covered Distribution Channel,End User,Cancer Indication,Patient Demographics,Disease Stage,Procedure Technique,Therapy Modality,Product Type

Regional Insights:

  • Leading Market (2024-2032): U.S., leading in terms of revenue 1.27 USD Billion in 2024
    • Key Country: U.S., leading in terms of revenue with value of 1,270.66 USD Million in 2024.

Segments and Scope

  • U.S. Cancer Photodynamic Therapy Market to 2032, By Distribution Channel
    • Direct Tender is the largest segment in U.S. Cancer Photodynamic Therapy Market to 2032 with a revenue of 629.87 USD Billion in the year 2024.
    • Direct Tender is the Fastest growing segment in U.S. Cancer Photodynamic Therapy Market to 2032 with a Growth rate of 6.69 % in forecast period 2025-2032.
  • U.S. Cancer Photodynamic Therapy Market to 2032, By End User
    • Hospitals is the largest segment in U.S. Cancer Photodynamic Therapy Market to 2032 with a revenue of 504.96 USD Billion in the year 2024.
    • Hospitals is the Fastest growing segment in U.S. Cancer Photodynamic Therapy Market to 2032 with a Growth rate of 7.18 % in forecast period 2025-2032.
  • U.S. Cancer Photodynamic Therapy Market to 2032, By Cancer Indication
    • Skin & Cutaneous Oncology is the largest segment in U.S. Cancer Photodynamic Therapy Market to 2032 with a revenue of 646.39 USD Billion in the year 2024.
    • Skin & Cutaneous Oncology is the Fastest growing segment in U.S. Cancer Photodynamic Therapy Market to 2032 with a Growth rate of 6.98 % in forecast period 2025-2032.
  • U.S. Cancer Photodynamic Therapy Market to 2032, By Patient Demographics
    • Geriatric is the largest segment in U.S. Cancer Photodynamic Therapy Market to 2032 with a revenue of 838.19 USD Billion in the year 2024.
    • Geriatric is the Fastest growing segment in U.S. Cancer Photodynamic Therapy Market to 2032 with a Growth rate of 6.63 % in forecast period 2025-2032.
  • U.S. Cancer Photodynamic Therapy Market to 2032, By Disease Stage
    • Early-Stage Cancer is the largest segment in U.S. Cancer Photodynamic Therapy Market to 2032 with a revenue of 1.03 USD Billion in the year 2024.
    • Early-Stage Cancer is the Fastest growing segment in U.S. Cancer Photodynamic Therapy Market to 2032 with a Growth rate of 6.47 % in forecast period 2025-2032.
  • U.S. Cancer Photodynamic Therapy Market to 2032, By Procedure Technique
    • External Beam is the largest segment in U.S. Cancer Photodynamic Therapy Market to 2032 with a revenue of 868.12 USD Billion in the year 2024.
    • Intracavitary (Endoscopic) Delivery is the Fastest growing segment in U.S. Cancer Photodynamic Therapy Market to 2032 with a Growth rate of 6.34 % in forecast period 2025-2032.
  • U.S. Cancer Photodynamic Therapy Market to 2032, By Therapy Modality
    • Standalone therapy is the largest segment in U.S. Cancer Photodynamic Therapy Market to 2032 with a revenue of 504.71 USD Billion in the year 2024.
    • Standalone therapy is the Fastest growing segment in U.S. Cancer Photodynamic Therapy Market to 2032 with a Growth rate of 6.92 % in forecast period 2025-2032.
  • U.S. Cancer Photodynamic Therapy Market to 2032, By Product Type
    • Photosensitizer Drugs is the largest segment in U.S. Cancer Photodynamic Therapy Market to 2032 with a revenue of 945.37 USD Billion in the year 2024.
    • Photosensitizer Drugs is the Fastest growing segment in U.S. Cancer Photodynamic Therapy Market to 2032 with a Growth rate of 6.52 % in forecast period 2025-2032.

U.S. Cancer Photodynamic Therapy Market Company Share Analysis

 
Company Name Company Share Analysis
Novartis AG
Bausch Health Companies Inc.
Advanz Pharma
Galderma
Photocure
U.S. Cancer Photodynamic Therapy Market Company Share Analysis

U.S. Cancer Photodynamic Therapy Market Geographical Sales Distribution, 2018-2032 USD Billion

U.S. Cancer Photodynamic Therapy Market Geographical Sales Distribution, 2018-2032 USD Billion

U.S. Cancer Photodynamic Therapy Market Company Profiling

U.S. Cancer Photodynamic Therapy Market Company Profiling

Industry Related Reports

South America Cold Sore Treatment Market
Middle East & Africa Cold Sore Treatment Market
North America Cold Sore Treatment Market
Europe Cold Sore Treatment Market
Asia-Pacific Cold Sore Treatment Market
Argentina Cold Sore Treatment Market
Australia Cold Sore Treatment Market
Austria Cold Sore Treatment Market
Belgium Cold Sore Treatment Market
Brazil Cold Sore Treatment Market
Frequently Asked Questions
The U.S. Cancer Photodynamic Therapy Market is segmented based on Segmentation Distribution Channel,End User,Cancer Indication,Patient Demographics,Disease Stage,Procedure Technique,Therapy Modality,Product Type.
U.S. Cancer Photodynamic Therapy Market was valued at USD 1.27(Revenue in USD Billion) in 2024.
U.S. Cancer Photodynamic Therapy Market is projected to grow at a CAGR of 6.38% during the forecast period of 2024 to 2032.
The Early-Stage Cancer segment is expected to dominate the U.S. Cancer Photodynamic Therapy Market, holding a largest market share of 1.03 USD Billion in 2024

U.S. Cancer Photodynamic Therapy Market Scope

U.S. Cancer Photodynamic Therapy Market Segmentation & Scope
Distribution Channel
  • Others
  • Online
  • Third Party Distributors
  • Direct Tender
End User
  • Others
  • Academic & Research Institutes
  • Ambulatory Surgical Centers (ASCS)
  • Dermatology & Skin-cancer clinics
  • Hospitals
Cancer Indication
  • Prostate
  • Cervical
  • Bladder
  • Lung
  • Esophagal
  • Head & Neck
  • Skin & Cutaneous Oncology
Patient Demographics
  • Pediatric
  • Adults
  • Geriatric
Disease Stage
  • Late-Stage Cancer
  • Early-Stage Cancer
Procedure Technique
  • Others
  • Interstitial (Internal) Delivery
  • Intracavitary (Endoscopic) Delivery
  • External Beam
Therapy Modality
  • Others
  • Palliation therapy
  • Adjunctive therapy
  • Standalone therapy
Product Type
  • Photodynamic Therapy Devices
  • Photosensitizer Drugs
Frequently Asked Questions
The U.S. Cancer Photodynamic Therapy Market is segmented based on Segmentation Distribution Channel,End User,Cancer Indication,Patient Demographics,Disease Stage,Procedure Technique,Therapy Modality,Product Type.
U.S. Cancer Photodynamic Therapy Market was valued at USD 1.27(Revenue in USD Billion) in 2024.
U.S. Cancer Photodynamic Therapy Market is projected to grow at a CAGR of 6.38% during the forecast period of 2024 to 2032.
The estimated market value of the U.S. Cancer Photodynamic Therapy Market for final year is USD 2.07 (USD Billion).

U.S. Cancer Photodynamic Therapy Market Company Profiling

U.S. Cancer Photodynamic Therapy Market Company Profiling
Frequently Asked Questions
The U.S. Cancer Photodynamic Therapy Market is segmented based on Segmentation Distribution Channel,End User,Cancer Indication,Patient Demographics,Disease Stage,Procedure Technique,Therapy Modality,Product Type.
U.S. Cancer Photodynamic Therapy Market was valued at USD 1.27(Revenue in USD Billion) in 2024.
U.S. Cancer Photodynamic Therapy Market is projected to grow at a CAGR of 6.38% during the forecast period of 2024 to 2032.
The estimated market value of the U.S. Cancer Photodynamic Therapy Market for final year is USD 2.07 (USD Billion).

Related Markets

HAVE A QUESTION?

Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.

BROWSE RELATED PAGES